Nilsine Partners’s Select Medical SEM Stock Holding History

Nilsine Partners’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,408	Closed	-$274K	–	398
2025 Q1	$274K	Buy	+16,408	New	+$302K	0.03%	313

Other funds holding SEM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

8KM

8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Nilsine Partners's SEM Position: Q2 2025 in Review

Nilsine Partners sold out of Select Medical (SEM) in Q2 2025, closing a stake of 16,408 shares — an estimated $274K sold.

Nilsine Partners first reported a position in SEM in Q1 2025 and held it in 1 quarter. The position peaked at $274K in Q1 2025. 262 funds tracked by Wall St. Rank hold SEM as of Q2 2025.

Nilsine Partners reported no remaining Select Medical position as of Q2 2025 after selling out during the quarter.
Nilsine Partners sold 16,408 Select Medical shares in Q2 2025, an estimated $274K.
Nilsine Partners first reported a position in Select Medical in Q1 2025 and held it in 1 quarter.
Nilsine Partners's Select Medical position peaked at $274K in Q1 2025.
262 funds tracked by Wall St. Rank held Select Medical as of Q2 2025.

Based on Nilsine Partners's 13F filing for Q2 2025, filed 31 Jul 2025.